Global $25 Billion Biosensors Market, 2022

DUBLIN, October 19, 2017 /PRNewswire/ --

The "Biosensors - A Global Market Overview" report has been added to Research and Markets' offering.

Global Biosensors market is expected to record a robust CAGR of about 9% during the 2017-2022 analysis period and is projected to touch US$25.9 billion by 2022 from an estimated US$16.9 billion in 2017.

Electrochemical estimated the largest global Biosensors market by technology with 2017 market stood at US$12 billion while Optical segment is expected the fastest growing Biosensor market worldwide with a CAGR of 10.5% over the same period.

Point of Care Testing is expected to remain the largest application area for Biosensors reaching a projected US$11.5 billion by 2022 growing at a CAGR of 8.1% between 2017 and 2022. In regional markets, Asia Pacific is expected the fastest growing market witnessing a CAGR of 11.4% for the aforementioned period whereas the North American market is estimated the largest end-user for Biosensors.

Key Business Trends

• Abbott's FreeStyle Libre Glucose Monitoring System Reimbursement in Japan
• Nanomedical Diagnostics' New NHS Agile Biosensor Chip for Use on Agile R100 Label-free Personal Assay System
• Abbott and Bigfoot Enter into Collaboration to Develop Diabetes Technologies
• New NTA Biosensor Chip Launched for use with Label-free Agile R100 Assay System
• Abbott to Expand its FreeStyle Libre Flash Glucose Monitoring System Coverage in Canada
• CE Mark for Abbott's TactiCath Contact Force Ablation Catheter
• Release of Fully Automated Solution for Cell Culture Sampling and Complete Analysis for Bench-Scale Bioreactor Cultures
• Nanomedical Diagnostics' AGILE R100 Graphene Biosensor Received Patent from USPTO
• Aerialtronics Joined Forces with RAE Systems BeNeLux for Developing the Altura Zenith ATX8 UAS
• BD's First Step in the Fight against Antimicrobial Resistance
• CardioMEMS HF System from Abbott Aid in Heart Failure Hospitalizations
• Nanomedical Diagnostics and Rogue Valley Microdevices Partnered to Deliver AGILE R100 Graphene Biosensor
• FLEXcon and Polestar Join Forces
• Finesse Solutions Acquired by Thermo Fisher Scientific
• PathSensors and USDA's Agricultural Research Service team to Develop Bio Sensor Technology for Citrus Greening Disease
• Cepheid Became an Indirect Wholly Owned Subsidiary of Danaher
• PathSensors, Inc Develops Universal BioSensor Technology
• PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays
• Smith Detection Enhances IONSCAN 600 Detector Capabilities
• MBiotech Acquired by Integrated DNA Technologies
• Biosensors International Enters into Distribution Agreement with CORDIS
• BioProfile FLEX2, the Next Addition to the BioProfile Line of Cell Culture Chemistry Analyzers
• Affymetrix Acquired by Thermo Fisher Scientific
• LifeScan Launches Onetouch Verio Flex Blood Glucose Monitoring System
• Animas Vibe Insulation Pump and Continuous Glucose Monitoring System Received FDA Approval for Diabetes Management in Children Ages Two and Older
• New Drger Tcore Sensor for Non-Invasive and Accurate Measurement of Body's Core Temperature
• Nanomedical Diagnostics, Inc. Launched to Supply Monitoring and Diagnostic Platforms
• QIAGEN, the First New Entrant in the US Market for STR Test Kits
• New Exotic Gas Sensors are Now Available for Honeywell's QRAE 3 Gas Detector
• LifeScan Launches the New OneTouch Verio Sync Meter

Key Market Trends